Chromosome aberrations in nine patients with ovarian cancer
other
OA: closed
public-domain-us
AI-generated summary
Cytogenetic analysis of nine ovarian cancer patients revealed complex numerical and structural alterations, with recurrent partial deletions suggesting gene loss contributes to tumor formation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Cytogenetic analysis was performed on 13 tumor specimens (six solid tissues and seven effusions) from nine patients with various types of ovarian cancer. Eight of these patients had not received cytotoxic therapy prior to the initial karyologic assessment. Extensive and complex numerical and structural alterations were seen in nearly all specimens. Consistent (clonal) abnormalities were found in each case, but karyotypic heterogeneity within a tumor was a consistent finding in this series. Aberrations of chromosomes 1, 3, 6, 7, 10, and 12 were each observed in five or more patients. Although no specific recurring translocations were observed, partial deletions of 3p, 6q, 8p, and 10q were each seen in three different cases. Breakpoints tended to recur at several chromosomal band regions, some of which appear to be near the known loci of certain protooncogenes. Double minute chromosomes were seen in one patient, and a homogeneously staining region was found in another. Karyotypic analysis was performed on one patient both before and after initiating chemotherapy, and the chromosome pattern became more complex after treatment. Overall, our findings indicate that karyotypes in newly diagnosed, untreated patients with ovarian cancer can be extremely complicated, and that the extent of chromosome change may increase with tumor progression. Furthermore, the recurrence of specific regional chromosome losses suggests that these sites contain genes whose loss plays a role in the formation of some ovarian tumors.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (30)
- Karyotype analysis of four solid gynecologic tumors via crossref
- doi:10.1002/1097-0142(197511)36:5<1729::aid-cncr2820360528>3.0.co;2-# via crossref
- doi:10.1002/1097-0142(197912)44:6<2108::aid-cncr2820440622>3.0.co;2-o via crossref
- doi:10.1016/0165-4608(81)90095-9 via crossref
- doi:10.1016/0165-4608(81)90037-6 via crossref
- doi:10.1016/0165-4608(84)90102-x via crossref
- doi:10.1016/0165-4608(85)90078-0 via crossref
- doi:10.1016/0165-4608(85)90075-5 via crossref
- doi:10.1016/0165-4608(85)90226-2 via crossref
- doi:10.1016/0165-4608(87)90070-7 via crossref
- doi:10.1016/0165-4608(87)90067-7 via crossref
- doi:10.1159/000132030 via crossref
- doi:10.3109/10520298809107166 via crossref
- doi:10.1159/000130716 via crossref
- doi:10.1002/ijc.2910210604 via crossref
- doi:10.1002/1097-0142(197908)44:2<604::aid-cncr2820440230>3.0.co;2-g via crossref
- doi:10.1016/0165-4608(82)90057-7 via crossref
- doi:10.1007/bf00295804 via crossref
- doi:10.1126/science.6274023 via crossref
- doi:10.1056/nejm198710293171803 via crossref
- doi:10.1016/0165-4608(88)90292-0 via crossref
- doi:10.1038/330578a0 via crossref
- doi:10.1016/0165-4608(87)90309-8 via crossref
- doi:10.1016/0165-4608(87)90310-4 via crossref
- doi:10.1016/0165-4608(82)90043-7 via crossref
- doi:10.1038/306494a0 via crossref
- doi:10.1126/science.3941898 via crossref
- doi:10.1200/jco.1984.2.1.8 via crossref
- doi:10.1016/0165-4608(86)90372-9 via crossref
- doi:10.1093/jnci/66.6.1021 via crossref
Source provenance
- crossref
- last seen: 2026-05-16T01:00:14.135816+00:00
- europepmc
- last seen: 2026-08-02T06:10:09.037253+00:00
- pubmed
- last seen: 2026-05-13T22:09:10.744835+00:00
- unpaywall
- last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine